Can basal cells be seen in adenocarcinoma of the prostate? An immunohistochemical study using high molecular weight cytokeratin (clone 34βE12) antibody

American Journal of Surgical Pathology

Volumn 26, Issue 9, 2002, Pages 1151-1160

  Oliai, Bahram R ^a   Kahane, Hillel ^b   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Dianon Systems   (United States)

Author keywords

34 E12; Adenocarcinoma; Basal cells; High grade prostatic intraepithelial neoplasia; Needle biopsy; Prostate

Indexed keywords

ANTIBODY; CYTOKERATIN ANTIBODY; EOSIN; HEMATOXYLIN; PEROXIDASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL CELL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLONING; MOLECULAR WEIGHT; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; SCORING SYSTEM;

ADENOCARCINOMA; BIOPSY, NEEDLE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MALE; MOLECULAR WEIGHT; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 0036724297     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200209000-00005     Document Type: Article

References (20)

1. Prostatic intraepithelial neoplasia and early invasion in prostate cancer
2. Keratin immunoreactivity in the benign and neoplastic human prostate
3. Benign mimics of prostate adenocarcinoma on needle biopsy
4. Cytokeratin 34βE12 immunoreactivity in benign prostatic acini: Quantitation, pattern assessment, and electron microscopic study
5. Anticytokeratin antibody 34β12 staining in prostate carcinoma
6. Use of keratin 903 as an adjunct in the diagnosis of prostatic carcinoma
7. Symposium on diagnosis and treatment of premalignant conditions: Precancerous lesions prostate
8. Immunohistochemical profile of prostatic and urothelial carcinoma impact of heat-induced epitope retrieval and presentation of tumors with intermediate features
9. Microcarcinoma in the prostate: Its association with duct-acinar dysplasia
10. Keratin profiles in normal/hyperplastic prostates and prostate carcinoma
11. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland
12. Keratin immunoreactivity in fine needle aspiration of the prostate: An aid in the differentiation of benign epithelium from well-differentiated adenocarcinoma
13. Basal cell-specific anti-keratin antibody 34βE12: Optimizing its use in distinguishing benign prostate and cancer
14. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate
15. Utility of immunohistochemical detection high molecular weight cytokeratin for differential diagnosis of proliferative conditions of the prostate
16. p63 is a prostate basal cell marker and is required for prostate development
17. Microscopic differential diagnosis of latent carcinoma of prostate
18. Effect of formalin fixation and epitope retrieval techniques on antibody 34βE12 immunostaining of prostatic tissue
19. The utility of basal cell-specific anticytokeratin antibody (34βE12) in the diagnosis of prostate cancer: A review of 228 cases
20. Rare expression of high molecular-weight cytokeratin in adenocarcinoma of the prostate gland: A study of 100 cases of metastatic and locally advanced prostate cancer